These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36853332)

  • 21. Assessment of structure-activity relationships and biased agonism at the Mu opioid receptor of novel synthetic opioids using a novel, stable bio-assay platform.
    Vasudevan L; Vandeputte M; Deventer M; Wouters E; Cannaert A; Stove CP
    Biochem Pharmacol; 2020 Jul; 177():113910. PubMed ID: 32179045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs).
    Rickli A; Luethi D; Reinisch J; Buchy D; Hoener MC; Liechti ME
    Neuropharmacology; 2015 Dec; 99():546-53. PubMed ID: 26318099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NBOMe: new potent hallucinogens--pharmacology, analytical methods, toxicities, fatalities: a review.
    Kyriakou C; Marinelli E; Frati P; Santurro A; Afxentiou M; Zaami S; Busardo FP
    Eur Rev Med Pharmacol Sci; 2015 Sep; 19(17):3270-81. PubMed ID: 26400534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Setup of a Serotonin 2A Receptor (5-HT2AR) Bioassay: Demonstration of Its Applicability To Functionally Characterize Hallucinogenic New Psychoactive Substances and an Explanation Why 5-HT2AR Bioassays Are Not Suited for Universal Activity-Based Screening of Biofluids for New Psychoactive Substances.
    Pottie E; Cannaert A; Van Uytfanghe K; Stove CP
    Anal Chem; 2019 Dec; 91(24):15444-15452. PubMed ID: 31725281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 25I-NBOMe related death in Australia: a case report.
    Kueppers VB; Cooke CT
    Forensic Sci Int; 2015 Apr; 249():e15-8. PubMed ID: 25747271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 25I-NBOMe, a phenethylamine derivative, induces adverse cardiovascular effects in rodents: possible involvement of p21 (CDC42/RAC)-activated kinase 1.
    Yoon KS; Gu SM; Cha HJ; Kim YH; Yun J; Lee JM
    Drug Chem Toxicol; 2022 Mar; 45(2):898-906. PubMed ID: 32597268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro assays for the functional characterization of (psychedelic) substances at the serotonin receptor 5-HT
    Pottie E; Stove CP
    J Neurochem; 2022 Jul; 162(1):39-59. PubMed ID: 34978711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The psychoactive drug 25B-NBOMe recapitulates rhabdomyolysis in zebrafish larvae.
    Kawahara G; Maeda H; Kikura-Hanajiri R; Yoshida KI; Hayashi YK
    Forensic Toxicol; 2017; 35(2):369-375. PubMed ID: 28890736
    [No Abstract]   [Full Text] [Related]  

  • 29. Neurotoxicological profile of the hallucinogenic compound 25I-NBOMe.
    Herian M; Wojtas A; Maćkowiak M; Wawrzczak-Bargiela A; Solarz A; Bysiek A; Madej K; Gołembiowska K
    Sci Rep; 2022 Feb; 12(1):2939. PubMed ID: 35190675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bad trip due to 25I-NBOMe: a case report from the EU project SPICE II plus.
    Hermanns-Clausen M; Angerer V; Kithinji J; Grumann C; Auwärter V
    Clin Toxicol (Phila); 2017 Sep; 55(8):922-924. PubMed ID: 28471280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Affinity, potency, efficacy, selectivity, and molecular modeling of substituted fentanyls at opioid receptors.
    Eshleman AJ; Nagarajan S; Wolfrum KM; Reed JF; Nilsen A; Torralva R; Janowsky A
    Biochem Pharmacol; 2020 Dec; 182():114293. PubMed ID: 33091380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Case series: toxicity from 25B-NBOMe--a cluster of N-bomb cases.
    Gee P; Schep LJ; Jensen BP; Moore G; Barrington S
    Clin Toxicol (Phila); 2016; 54(2):141-6. PubMed ID: 26621342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of
    Tirri M; Bilel S; Arfè R; Corli G; Marchetti B; Bernardi T; Boccuto F; Serpelloni G; Botrè F; De-Giorgio F; Golembiowska K; Marti M
    Front Psychiatry; 2022; 13():875722. PubMed ID: 35530025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 25X-NBOMe compounds - chemistry, pharmacology and toxicology. A comprehensive review.
    Herian M; Świt P
    Crit Rev Toxicol; 2023 Jan; 53(1):15-33. PubMed ID: 37115704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective and antagonist-dependent µ-opioid receptor activation by the combination of 2-{[2-(6-chloro-3,4-dihydro-1(2H)-quinolinyl)-2-oxoethyl]sulfanyl}-5-phenyl-4,6-(1H,5H)-pyrimidinedione and naloxone/naltrexone.
    Lin SY; Tien YW; Ke YY; Chang YC; Chang HF; Ou LC; Law PY; Xi JH; Tao PL; Loh HH; Chao YS; Shih C; Chen CT; Yeh SH; Ueng SH
    Bioorg Chem; 2022 Nov; 128():105905. PubMed ID: 35710525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The high frequency oscillation in orbitofrontal cortex is susceptible to phenethylamine psychedelic 25C-NBOMe in male rats.
    Yu ZP; Li Q; Wu ZX; Tang ZH; Zhang XQ; Wang ZC; Xu P; Shen HW
    Neuropharmacology; 2023 Apr; 227():109452. PubMed ID: 36724866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nano liquid chromatography-high-resolution mass spectrometry for the identification of metabolites of the two new psychoactive substances N-(ortho-methoxybenzyl)-3,4-dimethoxyamphetamine and N-(ortho-methoxybenzyl)-4-methylmethamphetamine.
    Caspar AT; Meyer MR; Westphal F; Weber AA; Maurer HH
    Talanta; 2018 Oct; 188():111-123. PubMed ID: 30029353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular Interaction Between Butorphanol and κ-Opioid Receptor.
    Ji J; Lin W; Vrudhula A; Xi J; Yeliseev A; Grothusen JR; Bu W; Liu R
    Anesth Analg; 2020 Sep; 131(3):935-942. PubMed ID: 32701545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comprehensive evaluation of the potential binding poses of fentanyl and its analogs at the µ-opioid receptor.
    Xie B; Goldberg A; Shi L
    Comput Struct Biotechnol J; 2022; 20():2309-2321. PubMed ID: 35615021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and Functional Characterization of 2-(2,5-Dimethoxyphenyl)-
    Pottie E; Kupriyanova OV; Shevyrin VA; Stove CP
    ACS Chem Neurosci; 2021 May; 12(9):1667-1673. PubMed ID: 33906351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.